327.47
0.47%
1.53
Finanzdaten der Bio Rad Laboratories Inc-Aktie (BIO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
10.33%
610.82
|
681.20 | 632.10 | 681.10 | 676.80 |
Cost Of Revenue |
9.54%
284.85
|
314.90 | 296.44 | 318.63 | 314.43 |
Gross Profit |
11.01%
325.97
|
366.30 | 335.70 | 362.50 | 362.40 |
Operating Expenses
|
3.77%
281.26
|
271.05 | 244.73 | 272.87 | 300.50 |
Interest Income/Expense |
0.68%
12.28
|
12.36 | 12.40 | 12.34 | 12.34 |
Benefits Costs and Expenses |
119.74
|
- | - | - | - |
Costs And Expenses |
119.74
|
- | - | - | - |
Operating Income/Loss |
53.10%
44.71
|
95.32 | 90.95 | 89.62 | 61.91 |
Income/Loss From Continuing Operations Before Tax |
27.91%
491.08
|
681.20 | 137.10 | -1,500.43 | 84.83 |
Income Tax Expense/Benefit |
36.19%
107.16
|
78.68 | 30.84 | -338.18 | 15.87 |
Income/Loss From Continuing Operations After Tax |
9.78%
383.92
|
349.70 | 106.30 | -1,162.30 | 69.00 |
Net Income/Loss
|
9.78%
383.92
|
349.70 | 106.30 | -1,162.30 | 69.00 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
20,470%
28.52
|
-0.14 | 29.10 | 29.36 | 29.60 |
Diluted Average Shares |
20,484%
28.54
|
-0.14 | 29.22 | 29.36 | 29.75 |
Basic Earnings Per Share |
10.78%
13.46
|
12.15 | 3.65 | -39.59 | 2.33 |
Diluted Earnings Per Share |
10.79%
13.45
|
12.14 | 3.64 | -39.59 | 2.32 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):